REDWOOD CITY, Calif. and HOFFMANN ESTATES, Ill., Jan. 13, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Tate & Lyle...
Protein engineering
Codexis Announces Pricing of Public Offering of Common Stock
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its...